Significant association between joint ultrasonographic parameters and synovial inflammatory factors in rheumatoid arthritis
Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with lo...
Saved in:
Published in | Arthritis research & therapy Vol. 21; no. 1; pp. 14 - 8 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
10.01.2019
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA).
A total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured.
Both US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1β and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity.
We demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA. |
---|---|
AbstractList | Background Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA). Methods A total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured. Results Both US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1β and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity. Conclusions We demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA. Background Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA). Methods A total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured. Results Both US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1[beta] and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity. Conclusions We demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA. Keywords: Ultrasonography, Rheumatoid arthritis/DG, Cytokines, Inflammation, Diagnostic imaging Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA). A total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured. Both US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1[beta] and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity. We demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA. Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA).BACKGROUNDUltrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA).A total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured.METHODSA total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured.Both US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1β and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity.RESULTSBoth US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1β and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity.We demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA.CONCLUSIONSWe demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA. Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA). A total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured. Both US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1β and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity. We demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA. Abstract Background Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to demonstrate increased blood flow and vascularization. Recently, echogenicity, especially hypoechoic synovium, has also been associated with local inflammatory activity. However, only a few studies have demonstrated correlation between histopathologic and immunopathologic evaluation and US findings. The aim of this study was to clarify whether joint US findings including synovial hypertrophy, vascularity, and echogenicity can accurately characterize synovial pathophysiology in patients with active rheumatoid arthritis (RA). Methods A total of 44 patients with RA were included, both treated (n = 25) and untreated (n = 19) and scheduled for US examination of the knee joint with synovial fluid (SF) aspiration and two treated patients also underwent synovial biopsy. US images were quantitatively analyzed using grayscale assessment of synovial hypertrophy and PD for vascularity and echogenicity. Levels of nine SF cytokines and growth factors were also measured. Results Both US synovial hypertrophy and PD vascularity significantly correlated with SF inflammatory cytokine levels such as IL-6, IL-8, IL-1β and IL-10 in untreated patients. Angiogenic factors, including vascular endothelial growth factor (VEGF), only correlated with PD vascularity. In the treated patients, the associations between synovial hypertrophy and any cytokines were diminished, although synovial vascularity and echogenicity correlated with IL-6 and VEGF (p < 0.05). Histopathologic analysis revealed that hypoechogenicity of the synovium correlated with marked infiltration of lymphocytes and hypervascularity. Conclusions We demonstrated the pathophysiological origins of US findings in the joint. The degree of US vascularity of the synovium correlated with local inflammatory cytokine levels and angiogenetic factors in patients with active RA. Synovial echogenicity, and not hypertrophy, correlated with inflammation, especially in treated patients with RA. |
ArticleNumber | 14 |
Audience | Academic |
Author | Inoue, Yumiko Takeuchi, Tsutomu Yoshimura, Akihiko Suzuki, Katsuya Yamaoka, Kunihiro Miyazaki, Takahiro Kondo, Yasushi Kaneko, Yuko Sakata, Koumei Takahashi, Chihiro Kassai, Yoshiaki Yasuoka, Hidekata Niki, Yasuo Takeshita, Masaru Morita, Rimpei |
Author_xml | – sequence: 1 givenname: Yasushi surname: Kondo fullname: Kondo, Yasushi – sequence: 2 givenname: Katsuya surname: Suzuki fullname: Suzuki, Katsuya – sequence: 3 givenname: Yumiko surname: Inoue fullname: Inoue, Yumiko – sequence: 4 givenname: Koumei surname: Sakata fullname: Sakata, Koumei – sequence: 5 givenname: Chihiro surname: Takahashi fullname: Takahashi, Chihiro – sequence: 6 givenname: Masaru surname: Takeshita fullname: Takeshita, Masaru – sequence: 7 givenname: Yoshiaki surname: Kassai fullname: Kassai, Yoshiaki – sequence: 8 givenname: Takahiro surname: Miyazaki fullname: Miyazaki, Takahiro – sequence: 9 givenname: Rimpei surname: Morita fullname: Morita, Rimpei – sequence: 10 givenname: Yasuo surname: Niki fullname: Niki, Yasuo – sequence: 11 givenname: Yuko surname: Kaneko fullname: Kaneko, Yuko – sequence: 12 givenname: Hidekata surname: Yasuoka fullname: Yasuoka, Hidekata – sequence: 13 givenname: Kunihiro surname: Yamaoka fullname: Yamaoka, Kunihiro – sequence: 14 givenname: Akihiko surname: Yoshimura fullname: Yoshimura, Akihiko – sequence: 15 givenname: Tsutomu surname: Takeuchi fullname: Takeuchi, Tsutomu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30630515$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktv1DAQxyNURB_wAbigSFy4pPgV27kgVRWPSpU4AGdr1nF2vUrsxXb6EF-e2W4p3QohH8Ya_-bvmdH_uDoIMbiqek3JKaVavs-UE9U2hOqGasKam2fVERVKN5JLdvDoflgd57wmhLGOiRfVISeSk5a2R9Wvb34Z_OAthFJDztF6KD6GeuHKtXOhXkePL_NYEuQY4jLBZuVtvYEEkysu5RpCX-fbEK88jLUPwwjTBCWm23oAizFjsk4rN2-zvq8hlVXyxeeX1fMBxuxe3ceT6senj9_PvzSXXz9fnJ9dNlYyWZoOWiqBWsVcP4hW8p53PQEluGqp1bxTWismoedW6IWgVLYtAQJMyIUiQvKT6mKn20dYm03yE6RbE8Gbu0RMS4M9eTs6g8octHSkX3DROaKpJZIpLoHxtrUKtT7stDbzYnK9dQEXM-6J7r8EvzLLeGUkZ0rIDgXe3Quk-HN2uZjJZ-vGEYKLczaMqo5zIQRB9O0TdB3nFHBVSEktpNCq-0stAQfA_Uf8125FzVmrqSCCcobU6T8oPL2bvEVbDR7zewVvHg_6MOEf6yBAd4BNMefkhgeEErO1p9nZ06A9zdae5gZr1JMa68ud37AbP_6n8jfapunb |
CitedBy_id | crossref_primary_10_1155_2020_4121524 crossref_primary_10_1080_14737159_2020_1707671 crossref_primary_10_1007_s00296_022_05256_4 crossref_primary_10_1093_rheumatology_keab504 crossref_primary_10_1186_s13052_025_01937_5 crossref_primary_10_1021_acscombsci_0c00169 crossref_primary_10_2478_rir_2022_0010 crossref_primary_10_1055_s_0044_1785471 crossref_primary_10_1080_14397595_2020_1847754 crossref_primary_10_14412_1996_7012_2023_3_76_81 crossref_primary_10_1111_1756_185X_13653 crossref_primary_10_1016_j_ejr_2022_08_002 crossref_primary_10_1007_s11596_020_2302_1 |
Cites_doi | 10.1136/annrheumdis-2012-202197 10.1016/S0278-2391(98)90868-0 10.1148/radiol.2251011272 10.1007/s11926-011-0201-y 10.1136/annrheumdis-2013-204603 10.1136/ard.2005.051250 10.1136/annrheumdis-2017-211458 10.1002/1529-0131(200109)44:9<2018::AID-ART350>3.0.CO;2-C 10.1002/art.39235 10.1002/art.22296 10.1002/1529-0131(200102)44:2<331::AID-ANR50>3.0.CO;2-0 10.1186/ar3293 10.1136/annrheumdis-2012-202669 10.1093/rheumatology/kep125 10.1186/ar3280 10.1002/art.10747 10.1186/s13075-015-0567-8 10.1080/14397595.2017.1337056 10.1111/j.1749-6632.2009.04388.x 10.1093/rheumatology/ket311 10.1002/art.1780330302 10.1136/ard.61.10.877 10.1097/BOR.0b013e32835fd8eb 10.3899/jrheum.130556 10.1136/ard.2004.023929 10.1136/ard.2005.051235 10.1136/ard.2010.138461 10.1002/acr.22303 10.1186/ar582 10.1002/art.1780310302 10.1136/ard.2009.117341 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2019 BioMed Central Ltd. Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s). 2019 |
Copyright_xml | – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s). 2019 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s13075-018-1802-x |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1478-6362 |
EndPage | 8 |
ExternalDocumentID | oai_doaj_org_article_39d3a86e0db349e081c062736a2355c7 PMC6327469 A581404132 30630515 10_1186_s13075_018_1802_x |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GrantInformation_xml | – fundername: Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan grantid: 25461484 – fundername: ; grantid: 25461484 |
GroupedDBID | --- .GJ 0R~ 23N 2WC 4.4 5GY 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABUWG ACGFS ACJQM ADBBV ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK E3Z EBD EBLON EJD EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE HZ~ INH INR ITC KQ8 M1P O5R O5S O9- PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ ROL RPM RSV SMD SOJ SV3 TR2 U2A UKHRP WOQ -5E -5G -A0 -BR 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF IAO IHR NPM Z7U PMFND 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c626t-9a516a1c72edf4563d39d0a743751c839788726ad3c48b4116550a0a246b70463 |
IEDL.DBID | 7X7 |
ISSN | 1478-6362 1478-6354 |
IngestDate | Wed Aug 27 01:07:09 EDT 2025 Thu Aug 21 13:41:31 EDT 2025 Thu Jul 10 17:11:50 EDT 2025 Fri Jul 25 22:21:42 EDT 2025 Tue Jun 17 21:46:29 EDT 2025 Tue Jun 10 20:29:01 EDT 2025 Thu Jan 02 22:58:46 EST 2025 Thu Apr 24 23:12:33 EDT 2025 Tue Jul 01 04:00:51 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Rheumatoid arthritis/DG Diagnostic imaging Inflammation Cytokines Ultrasonography |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c626t-9a516a1c72edf4563d39d0a743751c839788726ad3c48b4116550a0a246b70463 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/2168464879?pq-origsite=%requestingapplication% |
PMID | 30630515 |
PQID | 2168464879 |
PQPubID | 42876 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_39d3a86e0db349e081c062736a2355c7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6327469 proquest_miscellaneous_2179334440 proquest_journals_2168464879 gale_infotracmisc_A581404132 gale_infotracacademiconefile_A581404132 pubmed_primary_30630515 crossref_primary_10_1186_s13075_018_1802_x crossref_citationtrail_10_1186_s13075_018_1802_x |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-01-10 |
PublicationDateYYYYMMDD | 2019-01-10 |
PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-10 day: 10 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Arthritis research & therapy |
PublicationTitleAlternate | Arthritis Res Ther |
PublicationYear | 2019 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | M Carotti (1802_CR32) 2002; 61 WP Arend (1802_CR20) 1990; 33 M Walther (1802_CR10) 2002; 225 J Fukae (1802_CR15) 2014; 53 FC Arnett (1802_CR25) 1988; 31 C Pitzalis (1802_CR12) 2013; 25 K Ikeda (1802_CR5) 2013; 40 S Ohrndorf (1802_CR30) 2013; 72 R Kokebie (1802_CR21) 2011; 13 JM Koski (1802_CR28) 2006; 65 PC Taylor (1802_CR33) 2002; 4 R Caporali (1802_CR19) 2018; 77 M Walther (1802_CR13) 2001; 44 S Bugatti (1802_CR17) 2011; 13 E Naredo (1802_CR31) 2005; 64 D Aletaha (1802_CR26) 2010; 69 RJ Wakefield (1802_CR1) 2005; 32 J Strunk (1802_CR3) 2004; 31 M Szkudlarek (1802_CR27) 2001; 44 F Humby (1802_CR9) 2015; 67 HJ Ham van den (1802_CR24) 2009; 48 MA Karsdal (1802_CR23) 2011; 13 JM Koski (1802_CR11) 2006; 65 S Kelly (1802_CR14) 2015; 17 Y Tanaka (1802_CR34) 2018; 28 E Kubota (1802_CR22) 1998; 56 JH Ju (1802_CR4) 2007; 56 PG Conaghan (1802_CR2) 2003; 48 B Saleem (1802_CR8) 2010; 69 K Takase (1802_CR18) 2012; 30 M Andersen (1802_CR16) 2014; 73 M Backhous (1802_CR7) 2009; 1154 T Iwamoto (1802_CR6) 2014; 66 S Kelly (1802_CR29) 2015; 74 |
References_xml | – volume: 72 start-page: 69 year: 2013 ident: 1802_CR30 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2012-202197 – volume: 56 start-page: 192 year: 1998 ident: 1802_CR22 publication-title: J Oral Maxillofac Surg doi: 10.1016/S0278-2391(98)90868-0 – volume: 225 start-page: 225 year: 2002 ident: 1802_CR10 publication-title: Radiology doi: 10.1148/radiol.2251011272 – volume: 13 start-page: 440 year: 2011 ident: 1802_CR17 publication-title: Curr Rheumatol Rep doi: 10.1007/s11926-011-0201-y – volume: 74 start-page: 611 year: 2015 ident: 1802_CR29 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-204603 – volume: 65 start-page: 1658 year: 2006 ident: 1802_CR28 publication-title: Ann Rheum Dis doi: 10.1136/ard.2005.051250 – volume: 32 start-page: 2485 year: 2005 ident: 1802_CR1 publication-title: J Rheumatol – volume: 30 start-page: 85 year: 2012 ident: 1802_CR18 publication-title: Clin Exp Rheumatol – volume: 77 start-page: 18 year: 2018 ident: 1802_CR19 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2017-211458 – volume: 44 start-page: 2018 year: 2001 ident: 1802_CR27 publication-title: Arthritis Rheum doi: 10.1002/1529-0131(200109)44:9<2018::AID-ART350>3.0.CO;2-C – volume: 67 start-page: 2601 year: 2015 ident: 1802_CR9 publication-title: Arthritis Rheum doi: 10.1002/art.39235 – volume: 56 start-page: 214 year: 2007 ident: 1802_CR4 publication-title: Arthritis Rheum doi: 10.1002/art.22296 – volume: 44 start-page: 331 year: 2001 ident: 1802_CR13 publication-title: Arthritis Rheum doi: 10.1002/1529-0131(200102)44:2<331::AID-ANR50>3.0.CO;2-0 – volume: 13 start-page: R50 year: 2011 ident: 1802_CR21 publication-title: Arthritis Res Ther doi: 10.1186/ar3293 – volume: 73 start-page: 678 year: 2014 ident: 1802_CR16 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2012-202669 – volume: 48 start-page: 899 year: 2009 ident: 1802_CR24 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kep125 – volume: 13 start-page: 215 year: 2011 ident: 1802_CR23 publication-title: Arthritis Res Ther doi: 10.1186/ar3280 – volume: 48 start-page: 64 year: 2003 ident: 1802_CR2 publication-title: Arthritis Rheum doi: 10.1002/art.10747 – volume: 17 start-page: 58 year: 2015 ident: 1802_CR14 publication-title: Arthritis Res Ther doi: 10.1186/s13075-015-0567-8 – volume: 28 start-page: 58 year: 2018 ident: 1802_CR34 publication-title: Mod Rheumatol doi: 10.1080/14397595.2017.1337056 – volume: 1154 start-page: 139 year: 2009 ident: 1802_CR7 publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2009.04388.x – volume: 53 start-page: 586 year: 2014 ident: 1802_CR15 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/ket311 – volume: 33 start-page: 305 year: 1990 ident: 1802_CR20 publication-title: Arthritis Rheum doi: 10.1002/art.1780330302 – volume: 61 start-page: 877 year: 2002 ident: 1802_CR32 publication-title: Ann Rheum Dis doi: 10.1136/ard.61.10.877 – volume: 25 start-page: 334 year: 2013 ident: 1802_CR12 publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0b013e32835fd8eb – volume: 40 start-page: 1967 year: 2013 ident: 1802_CR5 publication-title: J Rheumatol doi: 10.3899/jrheum.130556 – volume: 64 start-page: 375 year: 2005 ident: 1802_CR31 publication-title: Ann Rheum Dis doi: 10.1136/ard.2004.023929 – volume: 31 start-page: 1004 year: 2004 ident: 1802_CR3 publication-title: J Rheumatol – volume: 65 start-page: 1590 year: 2006 ident: 1802_CR11 publication-title: Ann Rheum Dis doi: 10.1136/ard.2005.051235 – volume: 69 start-page: 1580 year: 2010 ident: 1802_CR26 publication-title: Ann Rheum Dis doi: 10.1136/ard.2010.138461 – volume: 66 start-page: 1576 year: 2014 ident: 1802_CR6 publication-title: Arthritis Care Res doi: 10.1002/acr.22303 – volume: 4 start-page: S99 issue: Suppl 3 year: 2002 ident: 1802_CR33 publication-title: Arthritis Res doi: 10.1186/ar582 – volume: 31 start-page: 315 year: 1988 ident: 1802_CR25 publication-title: Arthritis Rheum doi: 10.1002/art.1780310302 – volume: 69 start-page: 1636 year: 2010 ident: 1802_CR8 publication-title: Ann Rheum Dis doi: 10.1136/ard.2009.117341 |
SSID | ssj0022924 |
Score | 2.341534 |
Snippet | Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD) techniques to... Background Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler (PD)... Abstract Background Ultrasonography (US) can directly demonstrate joint inflammation, including grayscale (GS) signs of synovial hypertrophy and power Doppler... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 14 |
SubjectTerms | Aged Arthritis Arthritis, Rheumatoid - diagnostic imaging Arthritis, Rheumatoid - metabolism Blood & organ donations Blood flow Care and treatment Classification Cytokines Cytokines - metabolism Diagnosis Diagnostic imaging Endothelial growth factors Endothelium Female Humans Hypertrophy Inflammation Inflammation Mediators - metabolism Joint surgery Knee Knee Joint - diagnostic imaging Knee Joint - metabolism Lymphocytes Male Medical diagnosis Middle Aged Rheumatism Rheumatoid arthritis Rheumatoid arthritis/DG Rheumatoid factor Rheumatology Synovial Fluid - metabolism Ultrasonic imaging Ultrasonography Ultrasound imaging Vascular endothelial growth factor |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1baxQxFA7SB_FFvDtaJYIgCEPnkts8VrEUob5ooW8hk2TdkXa2dHelpX_e78xk1x0EffE1l2Fyzsm5kC9fGHtrlNRlEITza0UudNB5o4LJo4sB4dAIOVwUPvmijk_F5zN5tvPUF2HCRnrgUXAHdRNqZ1QsQluLJiKCeWLWrZWrECr9cI8cMW9TTKVSq0JZkc4wS6MOlvDUmkBqqJgMXMD1JAoNZP1_uuSdmDTFS-4EoKMH7H7KHPnh-McP2Z3YP2J3T9LZ-GN2-7X73hPwB7Li7rfUeYJi8R-LDj3rc3wcSfZIVd15TuTfFwSKWXLXB7686Rc_YZQcpgdruRhO4Xl6lgeN_Goe19TaBQ7pzQdSpCfs9OjTt4_HeXpaIfeoYFZ542SpXOl1FcMMOVQdIOfCIZ3QsvRImghkWCkXai9MK4ijRxaucJVQrSaSsadsr1_08TnjrpgZF10lYzOD1zVOqTCTTfBBIjiWIWPFRtTWJ95xev7i3A71h1F21I6Fdixpx15n7P12yuVIuvG3wR9If9uBxJc9NMCKbLIi-y8rytg70r6lXY2f8y5dTsASiR_LHkpiBkPArzK2PxmJ3ein3Rv7sckbLG1VKqR5KA2bjL3ZdtNMQrj1cbGmMfCUtRCiyNiz0dy2S6qJGA2JZ8b0xBAna5729N184ApXdaWFal78DyG9ZPeQLhK8DsF7n-2trtbxFVKyVft62H2_AFi0Mzw priority: 102 providerName: Directory of Open Access Journals |
Title | Significant association between joint ultrasonographic parameters and synovial inflammatory factors in rheumatoid arthritis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30630515 https://www.proquest.com/docview/2168464879 https://www.proquest.com/docview/2179334440 https://pubmed.ncbi.nlm.nih.gov/PMC6327469 https://doaj.org/article/39d3a86e0db349e081c062736a2355c7 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZtAqWX0nfdposKhULBxA-9fCqbkhAKCaXtwt6ELGmzLomd7qOk9M93RtbuxhRy8UGSjeUZzXwjjb8h5L0SXOaOYZ5fzVImnUwr4VTqjXfgDhXj4Ufhs3NxOmFfpnwaN9yWMa1yYxODoXadxT3ywyIX4CoBXlefrn-lWDUKT1djCY37ZB-py1Cr5XQXcBVVX9SWQaQEjpXFU81cicMl2G6JaWsQQykwCjcDvxTo-_830re81DCD8pZLOnlMHkUsSce98J-Qe759Sh6cxdPyZ-Tv9-aixVQg-HrU7ORAY3IW_dk10LO-hIcD7O7JqxtLkQ78CtNkltS0ji7_tN1vUFMKygj6cxXO5Wks1AONdDH3a2xtHAVFnAeapOdkcnL84_NpGostpBZimlVaGZ4Lk1tZeDcDVFW6snKZAYAheW4BRmHaYSGMKy1TNUPWHp6ZzBRM1BJpx16QvbZr_StCTTZTxpuC-2oGdlgZIdyMV846Du4ydwnJNp9a28hEjgUxLnWISJTQvXQ0SEejdPRNQj5ub7nuaTjuGnyE8tsORAbt0NAtLnRckBpmVxolfObqklUekJFFxuZSmAIgmJUJ-YDS17jO4eWsib8rwBSRMUuPOXKFAQQoEnIwGAnr0w67N_qjo31Y6p02J-TdthvvxJy31ndrHAO2s2SMZQl52avbdkolUqUBFE2IHCjiYM7DnraZB_ZwURaSier13a_1hjwEaIipdOCoD8jearH2bwF-repRWGMjsn90fP712yhsYsB1Uoz_AQw6MUA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxLMEChgJhIQUNXEcOzkgVB7VlnZ7oZX2Zhzb213UJmUf0Ir_xG9kJsnuNkLqrVfbieKd8Xyf1-NvAF5nMlWxE5TnV4hQKKfCXLos9MY7hMNMpPVF4f6B7B2Jr4N0sAZ_F3dhKK1yERPrQO0qS_-Rb_FYIlQivc4_nP0MqWoUna4uSmg0brHnL37jlm36fvcz2vcN5ztfDj_1wraqQGiRvM_C3KSxNLFV3Lsh0ofEJbmLDCKpSmOLfIHy67g0LrEiKwTJ06SRiQwXslCkr4XvvQE3EXgj2uypwWqDx_OmiK7AnRkCuWhPUeNMbk0RKxSlyeGeLcMgdN7BwbpcwP-gcAkVuxmblyBw5x7cbbkr226c7T6s-fIB3Oq3p_MP4c-38XFJqUdoLWZWdmdtMhj7UY2xZ36CL0ea34hljy0j-fFTSsuZMlM6Nr0oq1-4LBg6P_rraZ0HwNrCQNjIJiM_p9axY-j4o1qW6REcXYsZHsN6WZX-CTATDTPjDU99PsS4nxkp3TDNnXUpwnPsAogWP7W2rfI5FeA40fUOKJO6sY5G62iyjj4P4N3ykbNG9uOqwR_JfsuBpNhdN1STY90GAI2zS0wmfeSKROQemZglhehEGo6Uz6oA3pL1NcUV_Dhr2usROEVS6NLbKWmTIeXgAWx2RmI8sN3uhf_oNh5N9Wr1BPBq2U1PUo5d6as5jcFYnQghogA2GndbTikhaTakvgGojiN25tztKcejWq1cJlwJmT-9-rNewu3eYX9f7-8e7D2DO0hLKY0PScImrM8mc_8cqd-seFGvNwbfr3uB_wN_QWfF |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Significant+association+between+joint+ultrasonographic+parameters+and+synovial+inflammatory+factors+in+rheumatoid+arthritis&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Kondo%2C+Yasushi&rft.au=Suzuki%2C+Katsuya&rft.au=Inoue%2C+Yumiko&rft.au=Sakata%2C+Koumei&rft.date=2019-01-10&rft.pub=BioMed+Central&rft.issn=1478-6354&rft.eissn=1478-6362&rft.volume=21&rft_id=info:doi/10.1186%2Fs13075-018-1802-x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6362&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6362&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6362&client=summon |